Skip to main content
Acta Otorhinolaryngologica Italica logoLink to Acta Otorhinolaryngologica Italica
. 2013 Oct;33(5):320–323.

The rs39335 polymorphism of the RELN gene is not associated with otosclerosis in a southern Italian population

Il polimorfismo rs39335 del gene RELN non è associato con l'otosclerosi in una popolazione del Sud Italia

S IOSSA 1,2, V CORVINO 1, P GIANNINI 1, R SALVATO 1, M CAVALIERE 1, M PANETTI 3, G PANETTI 4, B PIANTEDOSI 4, E MARCIANO 1, A FRANZÈ 2,5,
PMCID: PMC3825038  PMID: 24227897

SUMMARY

Otosclerosis, the single most common cause of hearing impairment in white adults, is characterised by bone dystrophy localized to the otic capsule and isolated endochondral bone sclerosis with alternating phases of bone resorption and formation. Conductive hearing loss develops when otosclerotic foci invade the stapedio-vestibular joint (oval window) and interfere with free motion of the stapes, but affected subjects frequently develop profound sensorineural hearing loss. The aetiology of otosclerosis is unknown. In the last years, several association studies have been performed and have suggested that single nucleotide polymorphisms in some genes may be implicated in development of otosclerosis. The strongest association has been demonstrated for the reelin gene, located on chromosome 7q22.1, which encodes an extracellular matrix protein. The involvement of reelin in the pathogenesis of otosclerosis is controversial; it was identified in European and North African populations, but was excluded in an Indian population. To analyze the role of reelin in otosclerosis, it has been studied in a case-control analysis for the polymorphism rs39335 in a southern Italy population. In this population, the pathogenic link between the rs39335 variant and otosclerosis was excluded.

KEY WORDS: RELN gene, Otosclerosis, Single nucleotide polymorphism, rs39335

Introduction

Otosclerosis (OTSC) is the single most common cause of hearing impairment among white adults with a prevalence of 0.3-0.4% in the European population 1. Otosclerosis is characterized by bone dystrophy localised to the otic capsule and isolated endochondral bone sclerosis with alternating phases of bone resorption and formation: mature lamellar bone is removed by osteoclasts and replaced by osteoblasts with a thicker, more vascular bone.

Conductive hearing loss develops when otosclerotic foci invade the stapedio-vestibular joint (oval window) and interfere with free motion of the stapes, but about 10% of affected subjects develop profound neurosensorial hearing loss across all frequencies 2.

Mean age of onset is between the third decade, and 90% of affected individuals are under 50 years of age at the time of diagnosis. The aetiology of otosclerosis is unknown, although several theories have been postulated. For the familiar forms, which present a dominant form of transmission with reduced penetrance eight loci have been identified: OTSC1 (15q25-26) (OMIM 166800), OTSC2 (7q34-36) (OMIM 605727), OTSC3 (6p21.2-22.3) (OMIM 608244), OTSC4 (16q21-23.2) (OMIM 611571), OTSC5 (3q22-24) (OMIM 608787), OTSC7 (6q13-16.1) (OMIM 611572), OTSC8 (9p13.1-9q21.11) (OMIM 612096) and OTSC10 (1q41-44), but no causative gene has been yet identified 3-10. Moreover, in the last years several association studies have been performed and have suggested the implication of single nucleotide polymorphisms (SNPs) present in several genes in otosclerosis aetiology 11-15. For some genes the results are controversial.

In particular, an interesting and controversial case is represented by the reelin (RELN) gene which was associated in some populations, but not in others 14 16-18. The RELN gene, located on chromosome 7q22.1 and encoding the extracellular matrix protein reelin, is expressed by neural tissues 19 20. The results regarding reelin expression in the inner ear and in human stapes footplates are also controversial 14 21, making the aetiologic role of RELN in the pathogenesis of otosclerosis unclear. In previous studies, among the identified single nucleotide polymorphisms (SNPs) in RELN gene, the rs39335 variant was one of the most promising 16 17. In order to add information about a possible role of RELN in the aetiology of otosclerosis, we performed a case-control association study in a southern Italian population for the SNP rs39335.

Materials and methods

Patient selection

A total of 92 otosclerotic subjects were recruited by clinical centres present in Naples (Audiology and Othorhinolaryngology Units of University of Naples "Federico II"; Othorhinolaryngology Unit of "C. Ascalesi" Hospital, Naples, Italy). Subjects (65 females and 27 males) were all unrelated: age range 30-50 years. For 51 patients, clinical diagnosis was based on surgical findings during stapes surgery, while for the 41 remaining patients was based on audiological data 22 23. The control group was composed of 92 healthy individuals. Affected and control subjects are all originated from the Campania region. Written informed consent was obtained from all participants for DNA analysis according to the principles of the Helsinki Declaration.

SNP analysis and genotyping

Genomic DNA was extracted by conventional salt precipitation protocols from peripheral blood samples obtained in EDTA-containing tubes. For genotyping the rs39335 SNP in RELN the following primers were used (RELN1F 5'-GTCAATGATGAGGATGTTAATGTATA and RELN1R 5'-GAGAGAGACTAGCCAGAGGATC-3'): the RELN1F primer introduces a recognition site for the restriction enzyme Bstz17I. The primer pairs was designed using the PIRA PCR programme at http://cedar.genetics.soton.ac.uk/public_html/primer2.html. To amplify the region of interest in RELN, a polymerase chain reaction (PCR) was performed using 50 ng of purified genomic DNA in a PCR mix containing 10X Buffer II, 25 mM MgCl2, 5 U/μl Ampli Taq Gold; (Applied Biosystems) in the presence of 2.5 mM deoxynucleotide triphospate (dNTP) and 25 mM primers. For the RELN gene PCR was carried out with an initial denaturation cycle of 95°C for 10 min, 38 cycles with denaturation at 95°C for 1 min, annealing at 54°C for 1 min, elongation at 72°C for 1 min, and finally elongation at 72°C for 10 min. PCR products were digested overnight at 37°C according to the manufacturer's instructions.

Statistical analysis

The association of the rs39335 SNP with otosclerosis was analyzed by an exact chi-square test, comparing SNP frequencies using the software FINETTI (http://ihg2.helmholtz-muenchen.de.). Hardy-Weinberg equilibrium (HWE) of tested groups and Amirtage's trend test (ATT) as well as allele and genotype frequencies and odds ratios were also calculated using the FINETTI software.

Significant differences were considered to be when p < 0.05. Genotype and allele frequencies were compared between the two groups (otosclerotic subjects and healthy controls).

Results

Case-control analysis for the SNP rs39335

To add information about a potential pathogenic link between a rs39335 SNP and otosclerosis, a case-control study in 92 patients and 92 controls was performed using a restriction enzyme assay for the presence of the polymorphism rs39335, which was one of the more strongly associated SNPs in previous studies 16 17, with the G allele frequency higher in otosclerotic subjects than in controls. Table I shows the distribution of G allele frequencies in OTSC patients and healthy controls. In the examined population, it was less frequent in otosclerotic subjects than in controls. Table II shows the frequencies of the different genotypes (AA, AG, GG) in otosclerotic and control subjects. The AG and GG phenotypes were more frequent in control subjects, while the AA genotype was more frequent in otosclerotic subjects.

Table I.

Frequencies of the G allele between otosclerotic patients and control subjects.

SNP Position Sequence change Frequency in control subjects Frequency in otosclerotic patients
rs39335 28637145 A > G 42/184 (23%) 29/184 (16%)

Table II.

Genotype distribution of the RELN rs39335 SNP in otosclerotic patients and control subjects.

Genotype frequency
AA AG GG
Control 54 (59%) 34 (37%) 4 (4%)
OTSC 65 (71%) 25 (27%) 2 (2%)

The frequency of the G allele was 16% (29/184 alleles) in otosclerotic individuals compared to controls in which the frequency was 23% (42/184 alleles) (Table I). The difference in genotype distribution for the rs39335 SNP did not reach statistical significance (p = 0.0813; OR = 0.626; 95%CI: 0.37-1.07).

Discussion

Otosclerosis is a complex disease; although several studies have been carried out, the aetiopathogenesis of otosclerosis remains poorly understood. In the last years, several association studies suggesting that nucleotide variations in some genes may predispose to otosclerosis have been carried out 11-15. One of the genes analyzed was RELN for which a strong association in French, Belgian-Dutch German, Swiss, Romanian and northern Italian populations was demonstrated 14 16 17. This association was, however, not confirmed in an Indian population 18. Moreover, other data supporting the exclusion of the RELN gene as causative for otosclerosis are reported in a recent paper 21 where it was shown that this gene does not show active expression in adult stapes footplates.

Confirmatory studies in genotype-phenotype association are important for establishing the credibility of results. In fact, frequently, initial results cannot be confirmed. In this case-control study, both allele (Table I) and genotype (Table II) distributions of one of the most associated variants in previous works 16 17, the SNP rs39335, show no statistically significant association, suggesting that the rs39335 SNP is not a risk factor for otosclerosis.

Conclusions

The results obtained in this study show that, in the Campania population, there is no association between the rs39335 SNP and otosclerosis. Other variants, however, may still play a role in the disease. Further studies analyzing other variants and additional populations of different ethnic origin would be useful to verify the exact role of RELN in development of otosclerosis.

Acknowledgements

We thank all subjects who participated in the present project.

References

  • 1.Declau F, Spaendonck M, Timmermans JP, et al. Prevalence of otosclerosis in an unselected series of temporal bones. Adv Otol Neurotol. 2001;5:596–602. doi: 10.1097/00129492-200109000-00006. [DOI] [PubMed] [Google Scholar]
  • 2.Ramsay HA, Linthicum FH., Jr Mixed hearing loss in otosclerosis: indication for long-term follow-up. Am J Otol. 1994;15:536–539. [PubMed] [Google Scholar]
  • 3.Tomek MS, Brown MR, Mani SR, et al. Localization of a gene for otosclerosis to chromosome 15q25-q26. Hum Mol Genet. 1998;7:285–290. doi: 10.1093/hmg/7.2.285. [DOI] [PubMed] [Google Scholar]
  • 4.Bogaert K, Govaerts PJ, Schatteman I, et al. A second gene for otosclerosis, OTSC2, maps to chromosome 7q34-36. Am J Hum Genet. 2001;68:495–500. doi: 10.1086/318185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chen W, Campbell CA, Green GE, et al. Linkage of otosclerosis to a third locus (OTSC3) on human chromosome 6p21.3-22.3. J Med Genet. 2002;39:473–477. doi: 10.1136/jmg.39.7.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bogaert K, Leenheer EM, Chen W, et al. A fifth locus for otosclerosis, OTSC5, maps to chromosome 3q22- 24. J Med Genet. 2004;41:450–453. doi: 10.1136/jmg.2004.018671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brownstein Z, Goldfarb A, Levi H, et al. Chromosomal mapping and phenotypic characterization of hereditary otosclerosis linked to the OTSC4 locus. Arch Otolaryngol Head Neck Surg. 2006;132:416–424. doi: 10.1001/archotol.132.4.416. [DOI] [PubMed] [Google Scholar]
  • 8.Thys M, Bogaert K, Iliadou V, et al. A seventh locus for otosclerosis, OTSC7, maps to chromosome 6q13-16.1. Eur J Hum Genet. 2007;15:362–368. doi: 10.1038/sj.ejhg.5201761. [DOI] [PubMed] [Google Scholar]
  • 9.Bel Hadj Ali I, Thys M, Beltaief N, et al. A new locus for otosclerosis, OTSC8, maps to the pericentromeric region of chromosome 9. Hum Genet. 2008;123:267–272. doi: 10.1007/s00439-008-0470-3. [DOI] [PubMed] [Google Scholar]
  • 10.Schrauwen I, Weegerink NJ, Fransen E, et al. A new locus for otosclerosis, OTSC10, maps to chromosome 1q41-44. Clin Genet. 2011;79:495–497. doi: 10.1111/j.1399-0004.2010.01576.x. [DOI] [PubMed] [Google Scholar]
  • 11.Chen W, Meyer N, McKenna M, et al. Single-nucleotide polymorphisms in the COL1A1 regulatory regions are associated with otosclerosis. Clin Genet. 2007;71:406–414. doi: 10.1111/j.1399-0004.2007.00794.x. [DOI] [PubMed] [Google Scholar]
  • 12.Imauchi Y, Jeunemaitre X, Boussion M, et al. Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol Neurotol. 2008;29:295–301. doi: 10.1097/mao.0b013e318164d12c. [DOI] [PubMed] [Google Scholar]
  • 13.Schrauwen I, Thys M, Vanderstraeten K, et al. Association of bone morphogenetic proteins with otosclerosis. J Bone Miner Res. 2008;23:507–516. doi: 10.1359/JBMR.071112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schrauwen I, Ealy M, Huentelman MJ, et al. A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis. Am J Hum Genet. 2009;84:328–338. doi: 10.1016/j.ajhg.2009.01.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Thys M, Schrauwen I, Vanderstraeten K, et al. The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet. 2007;16:2021–2030. doi: 10.1093/hmg/ddm150. [DOI] [PubMed] [Google Scholar]
  • 16.Schrauwen I, Ealy M, Fransen E, et al. Genetic variants in the RELN gene are associated with otosclerosis in multiple European populations. Hum Genet. 2010;127:155–162. doi: 10.1007/s00439-009-0754-2. [DOI] [PubMed] [Google Scholar]
  • 17.Khalfallah A, Schrauwen I, Mnaja M, et al. Genetic variants in RELN are associated with otosclerosis in a non-European population from Tunisia. Ann Hum Genet. 2010;74:399–405. doi: 10.1111/j.1469-1809.2010.00595.x. [DOI] [PubMed] [Google Scholar]
  • 18.Priyadarshi S, Panda KC, Panda AK, et al. Lack of association between SNP rs3914132 of the RELN gene and otosclerosis in India. Genet Mol Res. 2010;9:1914–1920. doi: 10.4238/vol9-3gmr890. [DOI] [PubMed] [Google Scholar]
  • 19.Förster E, Bock HH, Herz J, et al. Emerging topics in reelin function. Eur J Neurosci. 2010;31:1511–1518. doi: 10.1111/j.1460-9568.2010.07222.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nielsen KB, Søndergaard A, Johansen MG, et al. Reelin expression during embryonic development of the pig brain. BMC Neurosci. 2010;11:75–75. doi: 10.1186/1471-2202-11-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Csomor P, Sziklai I, Karosi T. Controversies in RELN/reelin expression in otosclerosis. Eur Arch Otorhinolaryngol. 2012;269:431–440. doi: 10.1007/s00405-011-1653-4. [DOI] [PubMed] [Google Scholar]
  • 22.Leva F, D'Adamo P, Strollo L, et al. Otosclerosis: exclusion of linkage to the OTSC1 and OTSC2 loci in four Italian families. Int J Audiol. 2003;42:475–480. doi: 10.3109/14992020309081517. [DOI] [PubMed] [Google Scholar]
  • 23.Trivelli M, D'Ascanio L, Pappacena M, et al. Air- and boneconducted vestibular evoked myogenic potentials (VEMPs) in otosclerosis: recordings before and after stapes surgery. Acta Otorhinolaryngol Ital. 2010;30:5–10. [PMC free article] [PubMed] [Google Scholar]

Articles from Acta Otorhinolaryngologica Italica are provided here courtesy of Pacini Editore

RESOURCES